KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardlytics (CDLX) Net Margin (2017 - 2025)

Historic Net Margin for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to 139.67%.

  • Cardlytics' Net Margin rose 768300.0% to 139.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 44.12%, marking a year-over-year increase of 494300.0%. This contributed to the annual value of 68.02% for FY2024, which is 244600.0% down from last year.
  • Latest data reveals that Cardlytics reported Net Margin of 139.67% as of Q3 2025, which was up 768300.0% from 14.68% recorded in Q2 2025.
  • Cardlytics' Net Margin's 5-year high stood at 48.64% during Q1 2022, with a 5-year trough of 458.5% in Q4 2022.
  • Its 5-year average for Net Margin is 72.94%, with a median of 30.65% in 2023.
  • Per our database at Business Quant, Cardlytics' Net Margin tumbled by -4453600bps in 2022 and then soared by 3454200bps in 2023.
  • Over the past 5 years, Cardlytics' Net Margin (Quarter) stood at 13.14% in 2021, then tumbled by -3389bps to 458.5% in 2022, then surged by 75bps to 113.09% in 2023, then surged by 81bps to 21.07% in 2024, then plummeted by -563bps to 139.67% in 2025.
  • Its last three reported values are 139.67% in Q3 2025, 14.68% for Q2 2025, and 21.46% during Q1 2025.